Director Shareholding

AstraZeneca PLC 26 November 2002 DEALING BY DIRECTORS COMPANIES ACT 1985 SECTION 324/329 WE HEREBY INFORM YOU THAT, ON 25 NOVEMBER 2002, WE WERE NOTIFIED BY DR H L MOGREN, A DIRECTOR OF THE COMPANY, THAT, ON 25 NOVEMBER 2002, HE SOLD OPTIONS OVER ASTRAZENECA PLC ORDINARY SHARES OF USD0.25 EACH AS FOLLOWS:- NUMBER OF OPTIONS SOLD SALE PRICE PER OPTION DATE OF SALE 9,217 67.59SEK 25.11.02 THESE OPTIONS WERE ORIGINALLY GRANTED TO DR MOGREN OVER SHARES IN ASTRA AB UNDER THE ASTRA SHAREHOLDER VALUE INCENTIVE PLAN AND WERE CONVERTED INTO OPTIONS OVER ORDINARY SHARES IN ASTRAZENECA PLC IN APRIL 1999. DETAILS OF THE UNDERLYING ASTRAZENECA SHARES OVER WHICH THE OPTIONS WERE HELD ARE AS FOLLOWS:- NUMBER OF ASTRAZENECA SHARES OVER CLOSING PRICE OF ASTRAZENECA WHICH OPTIONS WERE HELD SHARES ON DATE OPTIONS WERE SOLD EFFECTIVE OPTION PRICE PER SHARE 12,400 298.28SEK 345SEK FOLLOWING THESE TRANSACTIONS, DR MOGREN HOLDS OPTIONS OVER 204,425 ORDINARY SHARES OF ASTRAZENECA PLC. G H R MUSKER COMPANY SECRETARY 26 NOVEMBER 2002 This information is provided by RNS The company news service from the London Stock Exchange

Companies

AstraZeneca (AZN)
UK 100